Evidence map›Paper›PMID 31630739›Full record

ArticleMethods in enzymology2019

Enzymatic synthesis and modification of high molecular weight DNA using terminal deoxynucleotidyl transferase.

Sonal Deshpande, Yunqi Yang, Ashutosh Chilkoti, Stefan Zauscher

Abstract read
In one paragraph

Article in Methods in enzymology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. The Protein-Templated Synthesis of Enzyme-Generated Aptamers.Angewandte Chemie (International ed. in English) · 2022
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sonal DeshpandeDepartment of Biomedical Engineering, Duke University, Durham, NC, United States.
Yunqi YangDepartment of Mechanical Engineering and Materials Science, Duke University, Durham, NC, United States.
Ashutosh ChilkotiDepartment of Biomedical Engineering, Duke University, Durham, NC, United States; Department of Mechanical Engineering and Materials Science, Duke University, Durham, NC, United States. Electronic address: chilkoti@duke.edu.
Stefan ZauscherDepartment of Biomedical Engineering, Duke University, Durham, NC, United States; Department of Mechanical Engineering and Materials Science, Duke University, Durham, NC, United States. Electronic address: zauscher@duke.edu.

Funding

In situ Enzymatic Synthesis of Aptamer Targeted Polynucleotide Drug Nanoparticles for Cancer TherapyR21EB026590 · NIBIB · DUKE UNIVERSITY · PI ZAUSCHER, STEFAN · 2018 to 2020
$621k
NIBIB NIH HHS R21 EB026590
6 · The paper itself

Abstract

The recognition that nucleic acids can be used as polymeric materials led to the blossoming of the field of DNA nanotechnology, with a broad range of applications in biotechnology, biosensors, diagnostics, and drug delivery. These applications require efficient methods to synthesize and chemically modify high molecular weight DNA. Here, we discuss terminal deoxynucleotidyl transferase (TdT)-catalyzed enzymatic polymerization (TcEP) as an alternative to conventional enzymatic and solid-phase DNA synthesis. We describe biochemical requirements for TcEP and provide step-by-step protocols to carry out TcEP in solution and from surfaces.

Indexed as

DNADNA NucleotidylexotransferaseMolecular WeightPolymerizationDNADNA NucleotidylexotransferaseDeoxynucleotidyl triphosphates (dNTPs)Deoxyribonucleic acid (DNA)Surface initiated enzymatic polymerization (SIEP)TdT-catalyzed enzymatic polymerization (TcEP)Terminal deoxynucleotidyl transferase (TdT)Unnatural nucleotides

Identifiers

PMID31630739
PMCPMC7241426

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.